CoChat

Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

The purpose of this study is to investigate whether the Y402H polymorphism (rs1061170, a T-to-C transition at amino acid position 402) in the complement factor H (CFH) gene have a pharmacogenetics effect on the anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD). We performed a meta-analysis using databases including PubMed and EMBASE to find relevant studies. 13 published association studies were selected for this meta-analysis, including 2704 patients. For the CFH Y402H polymorphism, anti-VEGF treatment was much less effective in AMD patients with the CFH CC genotype (CC versus TT: odds ratio (OR) = 55, 95% confidence interval (CI), 0.31 to 0.95, P = 0.03; CC versus CT: OR = 0.60, 95% CI, 0.40 to 0.91, P = 0.02; and CC versus CT + TT: OR = 0.59, 95% CI, 0.38 to 0.90, P = 0.02, respectively). In subgroup analysis, CFH Y402H polymorphism was more likely to be a predictor of response for Caucasians (CC versus CT+TT: OR = 0.63, 95% CI, 0.42 to 0.95, P = 0.03). In conclusion, pharmacogenetics of CFH Y402H polymorphism may play a role in response to anti-VEGF treatment for neovascular AMD, especially for Caucasians.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep14517

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram of studies included in this meta-analysis. CFH, complement factor H; VEGF, vascular endothelial growth factor.
Figure 1 Flow diagram of studies included in this meta-analysis. CFH, complement factor H; VEGF, vascular endothelial growth factor.CC BY · PubMed Central
Figure 2 The association between complement factor H Y402H and treatment response of neovascular AMD based on the recessive model. (A) Ovearall, (B) Caucasians, and (C) East Asians. M-H, Mantel-Haenszel statistics; CI, confidence interval.
Figure 2 The association between complement factor H Y402H and treatment response of neovascular AMD based on the recessive model. (A) Ovearall, (B) Caucasians, and (C) East Asians. M-H, Mantel-Haenszel statistics; CI, confidence interval.CC BY · PubMed Central
Figure 3 The association between complement factor H Y402H and treatment response of neovascular AMD based on studies that define a positive outcome only as improvement in visual acuity. M-H, Mantel-Haenszel statistics; CI, confidence interval.
Figure 3 The association between complement factor H Y402H and treatment response of neovascular AMD based on studies that define a positive outcome only as improvement in visual acuity. M-H, Mantel-Haenszel statistics; CI, confidence interval.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 31

Metadata

Authors
Chen, G., Tzekov, R., Li, W., Jiang, F., Mao, S., & Tong, Y.
Affiliations
  • Quzhou City People's Hospital (CN)
  • University of South Florida (US)
  • Xiamen University (CN)
Corresponding author
Li, Wensheng
Venue
Scientific Reports
Published
2015-09-28
Volume
5
Issue
1
Pages
14517-14517
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2432967877
Cited by
31
References
47
Citations by year
2025: 1 · 2024: 4 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 2
FWCI
0.74
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
complement factor H, CFH Y402H polymorphism, rs1061170, neovascular age-related macular degeneration, anti-VEGF therapy, pharmacogenetics, treatment response prediction, genetic association, Caucasians
MeSH terms
Alleles, Codon, Genotype, Humans, Macular Degeneration, Pharmacogenetics, Visual Acuity, Odds Ratio, Treatment Outcome, Complement Factor H, Amino Acid Substitution, Angiogenesis Inhibitors, Polymorphism, Single Nucleotide, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.